Watch Ticker

Palisade Bio, Inc. Common Stock

Go to Palisade Bio, Inc. Common Stock Website

$1.02

-0.02 (-1.92%)

Live

Previous Close

$1.04

Day Range

$1 - $1.0467

Previous Day Range

$1.01 - $1.08

Market Cap

$5.0 million USD

Day Vol.

70362

Previous Day Vol.

187150

Currency

USD

Primary Exchange

Nasdaq

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and i...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Palisade Bio, a clinical-stage biopharmaceutical company, announced an equity grant of 2,600 stock options to a new employee as an inducement to employment.

Related tickers: PALI.

Read Full Article

Palisade Bio, Inc. - Palisade Bio to Participate in the Virtual Investor Closing Bell Series